LYCOS RETRIEVER Beta Retriever Home  |  What is Lycos Retriever?   
Disease: Patients
built 657 days ago
Rosenbaum, Marlon S., M.D. The success of cardiac surgery in childhood has produced a large population of adults with congenital heart disease. These adults present a unique challenge for the cardiology community. With more than 30 different forms of congenital heart disease, it can be difficult for adult patients to find cardiologists familiar with their particular anatomy and problems. At the Columbia University Medical Center, highly specialized care of adults with congenital heart disease has been a long-standing tradition.
Where this new information really ought to make a difference is in patients whose doctors are recommending stent placement (as opposed to medical therapy) for stable coronary artery disease. Doctors are obligated to fully inform those patients of the risks of stent placement, and now, for the first time, one of the risks that they're obligated to describe is the possibility of a Plavix rebound.
More than 15 million Americans have a history of coronary heart disease. This year, an estimated 300,000 Americans will have a recurrent heart attack. The prevalence of coronary heart disease ... contributes to burdensome healthcare costs for patients as well as the nation's healthcare system. The American Heart Association expects direct and indirect costs of coronary heart disease to total nearly $152 billion in 2007.
Source:
VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase II clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.
The principal investigator ... has led studies showing that many of the changes in the brain characteristic of AD can be found in patients with critical coronary-artery disease or hypertension. Research indicates the onset of these diseases can occur approximately 10 to 15 years prior to the onset of the first signs of AD.
Source:
The author, a PH patient herself, knows what it is like to live with the disease. She talked to many other patients, doctors, and researchers while writing the Survival Guide. Dr. Bruce Brundage, a physician with a deep knowledge of PH, edited the book for accuracy.
SEARCH
MORE ABOUT